Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification

Journal of Lipid Research

Volumn 48, Issue 6, 2007, Pages 1353-1361

  Westerterp, Marit ^a,b   Berbée, Jimmy F P ^a,b   Delsing, Dianne J M ^a   Jong, Miek C ^a   Gijbels, Marion J J ^a,c   Dahlmans, Vivian E H ^a   Offerman, Erik H ^a   Romijn, Johannes A ^b   Havekes, Louis M ^a,b   Rensen, Patrick C N ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Lipoprotein; Lipoprotein lipase; Macrophage; Skin; Triglyceride

Indexed keywords

APOLIPOPROTEIN C1; FATTY ACID; OLEIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRICITY; ESTERIFICATION; FEMALE; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN TRANSPLANTATION; WILD TYPE;

ANIMALS; APOLIPOPROTEIN C-I; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTERIFICATION; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LIPOPROTEINS, VLDL; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OLEIC ACID; PHENOTYPE; PROTEIN BINDING; SKIN; SKIN ABNORMALITIES; SKIN TRANSPLANTATION;

EID: 34548149273     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700024-JLR200     Document Type: Article

References (45)

1. Lauer, S. J., D. Walker, N. A. Elshourbagy, C. A. Reardon, B. Levywilson, and J. M. Taylor. 1988. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263: 7277-7286.
2. Jong, M. C., M. H. Hofker, and L. M. Havekes. 1999. Role of ApoCs in lipoprotein metabolism - functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
3. van Ree, J. H., M. H. Hofker, W. J. A. A. van den Broek, J. M. A. van Deursen, H. van der Boom, R. R. Frants, B. Wieringa, and L. M. Havekes. 1995. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice. Biochem. J. 305: 905-911.
4. van Ree, J. H., W. J. A. A. van den Broek, A. van der Zee, V. E. H. Dahlmans, B. Wieringa, R. R. Frants, L. M. Havekes, and M. H. Hofker. 1995. Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members. Hum. Mol. Genet. 4: 1403-1409.
5. Jong, M. C., V. E. H. Dahlmans, P. J. J. van Gorp, K. W. van Dijk, M. L. Breuer, M. H. Hofker, and L. M. Havekes. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98: 2259-2267.
6. Berbee, J. F. P., C. C. van der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. N. Rensen. 2005. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J. Lipid Res. 46: 297-306.
7. Gautier, T., U. J. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers. 2006. Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. J. Lipid Res. 48: 30-40.
8. Westerterp, M., W. de Haan, J. F. Berbee, L. M. Havekes, and P. C. Rensen. 2006. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J. Lipid Res. 47: 1203-1211.
9. Jong, M. C., P. J. Voshol, M. Muurling, V. E. H. Dahlmans, J. A. Romijn, H. Pijl, and L. M. Havekes. 2001. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes. 50: 2779-2785.
10. Jong, M. C., M. J. J. Gijbels, V. E. H. Dahlmans, P. J. J. van Gorp, S. J. Koopman, M. Ponec, M. H. Hofker, and L. M. Havekes. 1998. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J. Clin. Invest. 101: 145-152.
11. Yagyu, H., T. Kitamine, J. Osuga, R. Tozawa, Z. Chen, Y. Kaji, T. Oka, S. Perrey, Y. Tamura, K. Ohashi, et al. 2000. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J. Biol. Chem. 275: 21324-21330.
12. Berbee, J. F., C. C. van der Hoogt, R. Kleemann, E. F. Schippers, R. L. Kitchens, J. T. van Dissel, I. A. Bakker-Woudenberg, L. M. Havekes, and P. C. Rensen. 2006. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J. 20: 2162-2164.
13. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
14. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
15. Rensen, P. C. N., M. C. M. van Dijk, E. C. Havenaar, M. K. Bijsterbosch, J. K. Kruijt, and T. J. C. van Berkel. 1995. Selective liver targeting of antivirals by recombinant chylomicrons - a new therapeutic approach to hepatitis B. Nat. Med. 1: 221-225.
16. Rensen, P. C. N., N. Herijgers, M. H. Netscher, S. C. J. Meskers, M. van Eck, and T. J. C. van Berkel. 1997. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J. Lipid Res. 38: 1070-1084.
17. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.
18. Knott, T. J., M. E. Robertson, L. M. Priestley, M. Urdea, S. Wallis, and J. Scott. 1984. Characterisation of mRNAs encoding the precursor for human apolipoprotein CI. Nucleic Acids Res. 12: 3909-3915.
19. Weinstock, P. H., C. L. Bisgaier, K. AaltoSetala, H. Radner, R. Ramakrishnan, S. Levak Frank, A. D. Essenburg, R. Zechner, and J. L. Breslow. 1995. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96: 2555-2568.
20. Weinstock, P. H., S. Levak Frank, L. C. Hudgins, H. Radner, J. M. Friedman, R. Zechner, and J. L. Breslow. 1997. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc. Natl. Acad. Sci. USA. 94: 10261-10266.
21. Yacoub, L. K., T. M. Vanni, and I. J. Goldberg. 1990. Lipoprotein lipase mRNA in neonatal and adult mouse tissues: comparison of normal and combined lipase deficiency (cld) mice assessed by in situ hybridization. J. Lipid Res. 31: 1845-1852.
22. Marcel, Y. L., M. Bergseth, and A. C. Nestruck. 1979. Preparative isoelectric focussing of apolipoproteins C and E from human very low density lipoproteins. Biochim. Biophys. Acta. 573: 175-183.
23. Bengtsson, G., and T. Olivecrona. 1979. Apolipoprotein CII enhances hydrolysis of monoglycerides by lipoprotein lipase, but the effect is abolished by fatty acids. FEBS Lett. 106: 345-348.
24. Bengtsson, G., and T. Olivecrona. 1980. Lipoprotein lipase. Mechanism of product inhibition. Eur. J. Biochem. 106: 557-562.
25. Posner, I., and J. De Sanctis. 1987. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II. Biochemistry. 26: 3711-3717.
26. Saxena, U., L. D. Witte, and I. J. Goldberg. 1989. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J. Biol. Chem. 264: 4349-4355.
27. Peterson, J., B. E. Bihain, G. Bengtsson-Olivecrona, R. J. Deckelbaum, Y. A. Carpentier, and T. Olivecrona. 1990. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc. Natl. Acad. Sci. USA. 87: 909-913.
28. Hirose, N., D. T. Blankenship, M. A. Krivanek, R. L. Jackson, and A. D. Cardin. 1987. Isolation and characterization of four heparinbinding cyanogen bromide peptides of human plasma apolipoprotein B. Biochemistry. 26: 5505-5512.
29. Weisgraber, K. H., and S. C. Rall, Jr. 1987. Human apolipoprotein B-100 heparin-binding sites. J. Biol. Chem. 262: 11097-11103.
30. Olsson, U., G. Camejo, S. O. Olofsson, and G. Bondjers. 1991. Molecular parameters that control the association of low density lipoprotein apo B-100 with chondroitin sulphate. Biochim. Biophys. Acta. 1097: 37-44.
31. Olsson, U., G. Camejo, and G. Bondjers. 1993. Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment. Biochemistry. 32: 1858-1865.
32. Clark, A. B., and S. H. Quarfordt. 1985. Apolipoprotein effects on the lipolysis of perfused triglyceride by heparin-immobilized milk lipase. J. Biol. Chem. 260: 4778-4783.
33. Chen, H. C., S. J. Smith, B. Tow, P. M. Elias, and R. V. Farese. 2002. Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands. J. Clin. Invest. 109: 175-181.
34. Cohen, P., M. Miyazaki, N. D. Socci, A. Hagge-Greenberg, W. Liedtke, A. A. Soukas, R. Sharma, L. C. Hudgins, J. M. Ntambi, and J. M. Friedman. 2002. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science. 297: 240-243.
35. Miyazaki, M., W. C. Man, and J. M. Ntambi. 2001. Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J. Nutr. 131: 2260-2268.
36. Smith, S. J., S. Cases, D. R. Jensen, H. C. Chen, E. Sande, B. Tow, D. A. Sanan, J. Raber, R. H. Eckel, and R. V. Farese. 2000. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25: 87-90.
37. Zheng, Y., K. J. Eilertsen, L. Ge, L. Zhang, J. P. Sundberg, S. M. Prouty, K. S. Stenn, and S. Parimoo. 1999. Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat. Genet. 23: 268-270.
38. Yen, C. L. E., M. Monetti, B. J. Burri, and R. V. Farese. 2005. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. J. Lipid Res. 46: 1502-1511.
39. Cheng, J. B., and D. W. Russell. 2004. Mammalian wax biosynthesis. II. Expression cloning of wax synthase cDNAs encoding a member of the acyltransferase enzyme family. J. Biol. Chem. 279: 37798-37807.
40. Farese, R. V., Jr., S. Cases, and S. J. Smith. 2000. Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase. Curr. Opin. Lipidol. 11: 229-234.
41. Seo, T., P. M. Oelkers, M. R. Giattina, T. S. Worgall, S. L. Sturley, and R. J. Deckelbaum. 2001. Differential modulation of ACAT1 and ACAT2 transcription and activity by long chain free fatty acids in cultured cells. Biochemistry. 40: 4756-4762.
42. Cheng, J. B., and D. W. Russell. 2004. Mammalian wax biosynthesis. I. Identification of two fatty acyl-coenzyme A reductases with different substrate specificities and tissue distributions. J. Biol. Chem. 279: 37789-37797.
43. Shi, H., M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116: 3015-3025.
44. Suganami, T., K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, et al. 2006. Role of the Toll like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27: 84-91.
45. McCulley, J. P., and G. F. Sciallis. 1977. Meibomian keratoconjunctivitis. Am. J. Ophthalmol. 84: 788-793.